We found a significant downregulation in CD31 expression in tumors from the SW620-miR-590-5p group compared with that from the SW620-control (Figure 2a), suggesting miR-590-5p may have antiangiogenic properties in CRC. Here, PECAM1 is linked to colorectal carcinoma.